All News #Library
Biotech
CANTEX TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
19 Mar 2024 //
PR NEWSWIRE
Cantex & Lenox Hill Hospital Announce Initiation of Phase 2 Study of Azeliragon
18 Sep 2023 //
PR NEWSWIRE
Cantex Pharma Announces Issuance Of A Patent For Azeliragon
16 May 2023 //
PR NEWSWIRE
Cantex Receives FDA Orphan Drug Designation for Azeliragon for Glioblastoma
09 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support